CYSTEINE HYDROCHLORIDE ANHYDROUS
UNII A9U1687S1S

Substance Identification & Data

This profile provides standardized clinical and technical data for Cysteine Hydrochloride Anhydrous, uniquely identified by the FDA Unique Ingredient Identifier (UNII) A9U1687S1S.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 52-89-1 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code

A9U1687S1S

CAS Registry Number

52-89-1

RxNorm Concept ID

N/A

Detailed Substance Profile

Preferred Name

CYSTEINE HYDROCHLORIDE ANHYDROUS

Official standardized name for this substance within the FDA UNII nomenclature system.

Molecular Formula

A9U1687S1S

The specific atomic composition represented as a molecular structure string.

InChIKey

C3H7NO2S.ClH

International Chemical Identifier digital signature for unique molecular identification.

SMILES String

IFQSXNOEEPCSLW-DKWTVANSSA-N

Line notation for describing the chemical structure and connectivity of atoms.

NCI Thesaurus

C77372

National Cancer Institute reference terminology for clinical and research data.

PubChem CID

60960

Unique identification number in the NCBI database of chemical substances.

Substance Type

CYSTEINE HYDROCHLORIDE ANHYDROUS

ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Ingredient Role

C([C@@H](N)CS)(=O)O.Cl

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Cysteine Hydrochloride Anhydrous. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.